{"id":99340,"date":"2021-02-04T22:50:36","date_gmt":"2021-02-04T22:50:36","guid":{"rendered":"https:\/\/raed.academy\/?p=99340"},"modified":"2021-02-05T15:04:04","modified_gmt":"2021-02-05T15:04:04","slug":"compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars","status":"publish","type":"post","link":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/","title":{"rendered":"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars"},"content":{"rendered":"<p><a href=\"https:\/\/raed.academy\/ca\/academics\/dr-francisco-lopez-munoz\/\" target=\"_blank\" rel=\"noopener\"><strong><em>Francisco L\u00f3pez Mu\u00f1oz<\/em><\/strong><\/a><br \/>\n<em>Professor de Farmacologia i vicerector de Recerca i Ci\u00e8ncia i director de l&#8217;Escola Internacional de Doctorat de la Universitat Camilo Jos\u00e9 Cela. Acad\u00e8mic de n\u00famero de la Reial Acad\u00e8mia Europea de Doctors-Barcelona 1914 (RAED)<\/em><\/p>\n<p><em>Article publicat a l&#8217;edici\u00f3 espanyola del portal acad\u00e8mic &#8220;The Conversation&#8221; i al diari digital &#8220;eldiario.es&#8221; el 26 i 27 de gener de 2021<\/em><\/p>\n<p><strong>Francisco L\u00f3pez Mu\u00f1oz<\/strong>, professor de Farmacologia de la <strong>Universitat Camilo Jos\u00e9 Cela<\/strong> i acad\u00e8mic de n\u00famero de la <strong>Reial Acad\u00e8mia Europea de Doctors-Barcelona 1914<\/strong> (RAED), aborda a l&#8217;article <strong>&#8220;Cuidado: los resultados de la plitidepsina de PharmaMar contra la COVID-19 siguen siendo preliminares&#8221;<\/strong>, publicat a l&#8217;edici\u00f3 espanyola del portal acad\u00e8mic <strong>&#8220;The Conversation&#8221;<\/strong> i al diari digital <strong>&#8220;eldiario.es&#8221;<\/strong> entre els passats 26 i 27 de gener, els primers resultats dels assajos realitzats per la farmac\u00e8utica gallega <strong>PharmaMar<\/strong> sobre els usos m\u00e8dics de la plitidepsina en la lluita contra la Covid-19. L&#8217;acad\u00e8mic signa aquest article al costat del professor de Farmacologia i Toxicologia de la <strong>Universitat Complutense de Madrid Jos\u00e9 Antonio Guerra Guirao<\/strong>. Tots dos autors ja van publicar un article sobre les possibilitats que obre aquest f\u00e0rmac antitumoral a l&#8217;inici dels assajos: <strong>&#8220;La plitidepsina ha demostrado su eficacia en bolsa: le falta hacerlo en pacientes de Covid-19&#8221;<\/strong>.<\/p>\n<p>Per a L\u00f3pez Mu\u00f1oz i Guerra Guirao, un cop q\u00fcestionats d&#8217;altres medicaments que van despertar grans expectatives com el Remdesivir o la hidroxicloroquina, cal tamb\u00e9 mantenir ara la cautela entre la comunitat cient\u00edfica un cop que la plitidepsina s&#8217;ha convertit en un element d&#8217;especulaci\u00f3 bors\u00e0ria. &#8220;Seria convenient, almenys en l&#8217;\u00e0mbit sanitari, deslligar els resultats obtinguts de la recerca biom\u00e8dica dels r\u00e8dits econ\u00f2mics i desitjar que les dades aportades puguin traduir-se en veritable esperan\u00e7a cl\u00ednica&#8221;, assenyalen els autors.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-99336\" src=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg\" sizes=\"(max-width: 500px) 100vw, 500px\" srcset=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg 500w, https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar-440x264.jpeg 440w\" alt=\"\" width=\"500\" height=\"300\" data-attachment-id=\"99336\" data-permalink=\"https:\/\/raed.academy\/cautela-con-el-ultimo-farmaco-contra-la-covid-19\/pharmamar\/\" data-orig-file=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg\" data-orig-size=\"500,300\" data-comments-opened=\"0\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"PharmaMar\" data-image-description=\"\" data-medium-file=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg\" data-large-file=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg\" \/>&#8220;Aquests dies, alguns mitjans han destacat d&#8217;una manera molt vehement els resultats. Per exemple, que redueix gaireb\u00e9 a el 100% la c\u00e0rrega viral de la SARS-CoV-2 i, fins i tot, que \u00e9s l&#8217;antiviral m\u00e9s potent que s&#8217;ha descrit mai. El president de la companyia productora tamb\u00e9 ha afirmat que amb dos o tres injeccions a dosis no t\u00f2xiques doblegarem la malaltia que produeix el coronavirus. Entenem que la comunicaci\u00f3 cient\u00edfica hauria de ser molt m\u00e9s prudent i cauta a l&#8217;hora d&#8217;informar sobre els resultats de aquest tipus d&#8217;assajos precl\u00ednics amb agents terap\u00e8utics destinats a una patologia tan rellevant, des del punt de vista sanitari i de repercussi\u00f3 social, com \u00e9s la Covid-19. Crear un ambient d&#8217;expectatives m\u00e0ximes entre la poblaci\u00f3 podria resultar contraproduent, fins i tot a curt termini&#8221;, expliquen.<\/p>\n<p>Els dos estudiosos, per\u00f2, no rebutgen les primeres conclusions del laboratori, que constaten que la plitidepsina posseeix una activitat antiviral in vitro 27,5 vegades m\u00e9s potent contra la SARS-CoV-2 que un altre antiviral usat en els primers moments de la pand\u00e8mia i ara q\u00fcestionat cl\u00ednicament, el Remdesivir. A l&#8217;estudi tamb\u00e9 es confirma, mitjan\u00e7ant l&#8217;\u00fas d&#8217;un mutant resistent a f\u00e0rmacs, que l&#8217;activitat antiviral de la plitidepsina contra el coronavirus que provoca la Covid-19 est\u00e0 intervinguda per la inhibici\u00f3 d&#8217;una diana biol\u00f2gica. Aix\u00ed mateix s&#8217;ha demostrat l&#8217;efic\u00e0cia in vivo del tractament amb plitidepsina en dos models de ratol\u00ed. En ells es va aconseguir una reducci\u00f3 de la replicaci\u00f3 viral en els pulmons en dos ordres de magnitud.<\/p>\n<p>&nbsp;<\/p>\n<h2><a href=\"https:\/\/theconversation.com\/cuidado-los-resultados-de-la-plitidepsina-contra-la-covid-19-siguen-siendo-preliminares-154046\" target=\"_blank\" rel=\"noopener\">Llegiu l&#8217;article a &#8220;The Conversation&#8221;<\/a><\/h2>\n<h2><a href=\"https:\/\/www.eldiario.es\/sociedad\/cuidado-resultados-plitidepsina-covid-19-siguen-preliminares_129_7170886.html\" target=\"_blank\" rel=\"noopener\">Llegiu l&#8217;article a &#8220;eldiario.es&#8221;<\/a><\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Francisco L\u00f3pez Mu\u00f1oz adverteix en el seu article que els resultats dels assajos realitzats per PharmaMar sobre els usos m\u00e8dics de la plitidepsina en la lluita contra la Covid-19 segueixen sent preliminars<\/p>\n","protected":false},"author":12,"featured_media":99337,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[268,274,273],"tags":[],"class_list":["post-99340","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coronavirus-des-del-coneixement","category-economia-i-politica","category-salut","et-has-post-format-content","et_post_format-et-post-format-standard"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars - Reial Acad\u00e8mia Europea de Doctors<\/title>\n<meta name=\"description\" content=\"Francisco L\u00f3pez Mu\u00f1oz adverteix sobre els resultats dels assajos realitzats per PharmaMar sobre els usos m\u00e8dics de la plitidepsina contra la Covid-19\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars - Reial Acad\u00e8mia Europea de Doctors\" \/>\n<meta property=\"og:description\" content=\"Francisco L\u00f3pez Mu\u00f1oz adverteix sobre els resultats dels assajos realitzats per PharmaMar sobre els usos m\u00e8dics de la plitidepsina contra la Covid-19\" \/>\n<meta property=\"og:url\" content=\"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/\" \/>\n<meta property=\"og:site_name\" content=\"Reial Acad\u00e8mia Europea de Doctors\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/fb.me\/raed.academy\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-04T22:50:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-05T15:04:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"RAED\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@raedacademy\" \/>\n<meta name=\"twitter:site\" content=\"@raedacademy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"RAED\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/\"},\"author\":{\"name\":\"RAED\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/person\\\/5a755da80d1d979fd66ba745c8702927\"},\"headline\":\"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars\",\"datePublished\":\"2021-02-04T22:50:36+00:00\",\"dateModified\":\"2021-02-05T15:04:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/\"},\"wordCount\":615,\"publisher\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/PharmaMar.jpeg\",\"articleSection\":[\"Coronavirus des del coneixement\",\"Economia i pol\u00edtica\",\"Salut\"],\"inLanguage\":\"ca-ES\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/\",\"name\":\"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars - Reial Acad\u00e8mia Europea de Doctors\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/PharmaMar.jpeg\",\"datePublished\":\"2021-02-04T22:50:36+00:00\",\"dateModified\":\"2021-02-05T15:04:04+00:00\",\"description\":\"Francisco L\u00f3pez Mu\u00f1oz adverteix sobre els resultats dels assajos realitzats per PharmaMar sobre els usos m\u00e8dics de la plitidepsina contra la Covid-19\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/#breadcrumb\"},\"inLanguage\":\"ca-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/#primaryimage\",\"url\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/PharmaMar.jpeg\",\"contentUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/PharmaMar.jpeg\",\"width\":500,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#website\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\",\"name\":\"Reial Acad\u00e8mia Europea de Doctors\",\"description\":\"Corporaci\u00f3n de derecho p\u00fablico de car\u00e1cter cient\u00edfico, t\u00e9cnico y art\u00edstico, que tiene por objeto la investigaci\u00f3n, el estudio, el fomento y la extensi\u00f3n del conocimiento en su sentido m\u00e1s amplio\",\"publisher\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/raed.academy\\\/ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#organization\",\"name\":\"Real Academia Europea de Doctores\",\"url\":\"https:\\\/\\\/raed.academy\\\/ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/cropped-logo_raed.png\",\"contentUrl\":\"https:\\\/\\\/raed.academy\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/cropped-logo_raed.png\",\"width\":512,\"height\":512,\"caption\":\"Real Academia Europea de Doctores\"},\"image\":{\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/fb.me\\\/raed.academy\",\"https:\\\/\\\/x.com\\\/raedacademy\",\"https:\\\/\\\/www.instagram.com\\\/raed.academy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCUYQwW2KrdirNWihxMDObwg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/raed.academy\\\/ca\\\/#\\\/schema\\\/person\\\/5a755da80d1d979fd66ba745c8702927\",\"name\":\"RAED\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca-ES\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g\",\"caption\":\"RAED\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars - Reial Acad\u00e8mia Europea de Doctors","description":"Francisco L\u00f3pez Mu\u00f1oz adverteix sobre els resultats dels assajos realitzats per PharmaMar sobre els usos m\u00e8dics de la plitidepsina contra la Covid-19","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/","og_locale":"ca_ES","og_type":"article","og_title":"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars - Reial Acad\u00e8mia Europea de Doctors","og_description":"Francisco L\u00f3pez Mu\u00f1oz adverteix sobre els resultats dels assajos realitzats per PharmaMar sobre els usos m\u00e8dics de la plitidepsina contra la Covid-19","og_url":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/","og_site_name":"Reial Acad\u00e8mia Europea de Doctors","article_publisher":"http:\/\/fb.me\/raed.academy","article_published_time":"2021-02-04T22:50:36+00:00","article_modified_time":"2021-02-05T15:04:04+00:00","og_image":[{"width":500,"height":300,"url":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg","type":"image\/jpeg"}],"author":"RAED","twitter_card":"summary_large_image","twitter_creator":"@raedacademy","twitter_site":"@raedacademy","twitter_misc":{"Written by":"RAED","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/#article","isPartOf":{"@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/"},"author":{"name":"RAED","@id":"https:\/\/raed.academy\/ca\/#\/schema\/person\/5a755da80d1d979fd66ba745c8702927"},"headline":"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars","datePublished":"2021-02-04T22:50:36+00:00","dateModified":"2021-02-05T15:04:04+00:00","mainEntityOfPage":{"@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/"},"wordCount":615,"publisher":{"@id":"https:\/\/raed.academy\/ca\/#organization"},"image":{"@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/#primaryimage"},"thumbnailUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg","articleSection":["Coronavirus des del coneixement","Economia i pol\u00edtica","Salut"],"inLanguage":"ca-ES"},{"@type":"WebPage","@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/","url":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/","name":"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars - Reial Acad\u00e8mia Europea de Doctors","isPartOf":{"@id":"https:\/\/raed.academy\/ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/#primaryimage"},"image":{"@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/#primaryimage"},"thumbnailUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg","datePublished":"2021-02-04T22:50:36+00:00","dateModified":"2021-02-05T15:04:04+00:00","description":"Francisco L\u00f3pez Mu\u00f1oz adverteix sobre els resultats dels assajos realitzats per PharmaMar sobre els usos m\u00e8dics de la plitidepsina contra la Covid-19","breadcrumb":{"@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/#breadcrumb"},"inLanguage":"ca-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/"]}]},{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/#primaryimage","url":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg","contentUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2021\/02\/PharmaMar.jpeg","width":500,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/raed.academy\/ca\/compte-els-resultats-de-la-plitidepsina-de-pharmamar-contra-la-covid-19-son-encara-preliminars\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/raed.academy\/ca\/"},{"@type":"ListItem","position":2,"name":"Compte: els resultats de la plitidepsina de PharmaMar contra la COVID-19 s\u00f3n encara preliminars"}]},{"@type":"WebSite","@id":"https:\/\/raed.academy\/ca\/#website","url":"https:\/\/raed.academy\/ca\/","name":"Reial Acad\u00e8mia Europea de Doctors","description":"Corporaci\u00f3n de derecho p\u00fablico de car\u00e1cter cient\u00edfico, t\u00e9cnico y art\u00edstico, que tiene por objeto la investigaci\u00f3n, el estudio, el fomento y la extensi\u00f3n del conocimiento en su sentido m\u00e1s amplio","publisher":{"@id":"https:\/\/raed.academy\/ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/raed.academy\/ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca-ES"},{"@type":"Organization","@id":"https:\/\/raed.academy\/ca\/#organization","name":"Real Academia Europea de Doctores","url":"https:\/\/raed.academy\/ca\/","logo":{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/raed.academy\/ca\/#\/schema\/logo\/image\/","url":"https:\/\/raed.academy\/wp-content\/uploads\/2017\/01\/cropped-logo_raed.png","contentUrl":"https:\/\/raed.academy\/wp-content\/uploads\/2017\/01\/cropped-logo_raed.png","width":512,"height":512,"caption":"Real Academia Europea de Doctores"},"image":{"@id":"https:\/\/raed.academy\/ca\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/fb.me\/raed.academy","https:\/\/x.com\/raedacademy","https:\/\/www.instagram.com\/raed.academy\/","https:\/\/www.youtube.com\/channel\/UCUYQwW2KrdirNWihxMDObwg"]},{"@type":"Person","@id":"https:\/\/raed.academy\/ca\/#\/schema\/person\/5a755da80d1d979fd66ba745c8702927","name":"RAED","image":{"@type":"ImageObject","inLanguage":"ca-ES","@id":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/19fdfdc0d67fb9c45714b703a2ac82251c4fcea3637f002ac3c9b74c0183583c?s=96&d=mm&r=g","caption":"RAED"}}]}},"_links":{"self":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts\/99340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/comments?post=99340"}],"version-history":[{"count":0,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/posts\/99340\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/media\/99337"}],"wp:attachment":[{"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/media?parent=99340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/categories?post=99340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/raed.academy\/ca\/wp-json\/wp\/v2\/tags?post=99340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}